Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ACADEMIA
ACADEMIA
- JUA Negative about OTC Switching of Propiverine Hydrochloride
November 17, 2011
- PSJ Preparing for Exchange of Views with JAMS on Switch-OTC Drug Candidates
November 15, 2011
- Teriparatide “Strongly Recommended” for Non-vertebral Fracture: JOS Draft GLs
November 7, 2011
- “No Major Ethnic Differences” in Pharmacokinetics of 3 Drugs Reported
November 1, 2011
- JSGM Calls for Elimination of GE Drug Refusal Option in Prescriptions
October 28, 2011
- JSGM Calls For Elimination of GE Drug Refusal Option in Prescriptions
October 27, 2011
- “No Major Differences” Between 4 AD Treatments; More Evidence Needed: Prof. Hanyu
October 20, 2011
- Kyowa Kirin’s KW-0761 Shows Promise for ATL: Prof. Tsukasaki of Nagasaki Univ.
October 20, 2011
- Positive Results for Avastin in Japanese PII Trial in Recurrent GBM: JNS
October 13, 2011
- Nexium Significantly Reduces Incidence of Acid Reflux Compared to Omepral: Study Report
October 10, 2011
- Prof. Uchiyama Stresses Need for Caution with Prazaxa Even at Low Dose
October 10, 2011
- JGS Opposes OTC Switch for 8 Ethical Drugs on Ground of Patients’ High Ages
October 7, 2011
- HRT is Cost Efficient Treatment: JSMWH
October 6, 2011
- Humira Top Choice Among Biopharmaceuticals for Psoriasis Treatment: Prof. Nakagawa
October 6, 2011
- Patients Need to Be Warned of Risk of Relapse if They Discontinue Antidepressants: Prof. Iwata
October 6, 2011
- Med. Institutions Prefer GE Anticancer Drugs from Companies with Better Support Systems: Ms Matsui of NCC Hospital East
October 3, 2011
- Decision to Prescribe Prazaxa Should Be Left to Specialists for Now: JCS Press Seminar
September 30, 2011
- 95% of Patients Favor Comprehensive Agreements to Use Tissue for Research: NCC
September 26, 2011
- JASSO to Announce New Diagnostic Guidelines for Obesity
September 26, 2011
- Insurers Favor Incentives to Pharmacies to Promote Use of Generics: Seminar
September 26, 2011
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…